| Nome |
# |
|
Rheumatoid arthritis: Extra-articular manifestations and comorbidities, file e2f56eda-c418-3eaf-e053-3a05fe0a5d97
|
1.909
|
|
How Do Patients with Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria, file e2f56ed7-c00c-3eaf-e053-3a05fe0a5d97
|
777
|
|
null, file e2f56ed8-8fc5-3eaf-e053-3a05fe0a5d97
|
703
|
|
Methotrexate and vasculoprotection: Mechanistic insights and potential therapeutic applications in old age, file e2f56ed9-0207-3eaf-e053-3a05fe0a5d97
|
591
|
|
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care, file e2f56ed6-dff6-3eaf-e053-3a05fe0a5d97
|
565
|
|
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study, file e2f56ed7-c011-3eaf-e053-3a05fe0a5d97
|
565
|
|
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes, file e2f56ed7-c010-3eaf-e053-3a05fe0a5d97
|
537
|
|
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study, file e2f56ed7-baca-3eaf-e053-3a05fe0a5d97
|
446
|
|
null, file e2f56ed6-1c07-3eaf-e053-3a05fe0a5d97
|
355
|
|
Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: A monocentric cross-sectional study, file e2f56ed9-87c3-3eaf-e053-3a05fe0a5d97
|
325
|
|
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset, file e2f56ed7-8426-3eaf-e053-3a05fe0a5d97
|
313
|
|
Overexpression of the cytokine BAFF and autoimmunity risk, file e2f56ed6-7b51-3eaf-e053-3a05fe0a5d97
|
298
|
|
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests, file e2f56ed4-abc4-3eaf-e053-3a05fe0a5d97
|
207
|
|
Physician global assessment in systemic lupus erythematosus: Can we rely on its reliability?, file e2f56ed9-60db-3eaf-e053-3a05fe0a5d97
|
187
|
|
null, file e2f56ed7-c013-3eaf-e053-3a05fe0a5d97
|
186
|
|
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage, file e2f56ed9-b6ca-3eaf-e053-3a05fe0a5d97
|
185
|
|
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group, file e2f56eda-b340-3eaf-e053-3a05fe0a5d97
|
185
|
|
null, file e2f56ed5-8d51-3eaf-e053-3a05fe0a5d97
|
171
|
|
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study, file e2f56eda-afbc-3eaf-e053-3a05fe0a5d97
|
164
|
|
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort, file e2f56ed9-4dfe-3eaf-e053-3a05fe0a5d97
|
152
|
|
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series, file e2f56ed7-361a-3eaf-e053-3a05fe0a5d97
|
147
|
|
Polymyalgia rheumatica: an autoinflammatory disorder?, file e2f56ed7-e9af-3eaf-e053-3a05fe0a5d97
|
147
|
|
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease, file e2f56ed7-1570-3eaf-e053-3a05fe0a5d97
|
136
|
|
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence, file e2f56eda-bffb-3eaf-e053-3a05fe0a5d97
|
136
|
|
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis), file e2f56ed5-8610-3eaf-e053-3a05fe0a5d97
|
133
|
|
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09, file e2f56ed5-260a-3eaf-e053-3a05fe0a5d97
|
132
|
|
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study, file e2f56ed7-3ee7-3eaf-e053-3a05fe0a5d97
|
132
|
|
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study, file ebf15040-c1b5-44df-a9dd-f1818e7ab7c4
|
126
|
|
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus, file e2f56ed7-0690-3eaf-e053-3a05fe0a5d97
|
125
|
|
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients, file e2f56ed5-8bc3-3eaf-e053-3a05fe0a5d97
|
121
|
|
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus, file e2f56ed7-7805-3eaf-e053-3a05fe0a5d97
|
118
|
|
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome, file e2f56eda-d219-3eaf-e053-3a05fe0a5d97
|
109
|
|
null, file e2f56ed7-afd9-3eaf-e053-3a05fe0a5d97
|
105
|
|
Protective effects of methotrexate against proatherosclerotic cytokines: a review of the evidence, file e2f56ed7-3eed-3eaf-e053-3a05fe0a5d97
|
103
|
|
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study, file e2f56ed6-d803-3eaf-e053-3a05fe0a5d97
|
100
|
|
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population, file e2f56ed7-be56-3eaf-e053-3a05fe0a5d97
|
93
|
|
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome, file e2f56ed8-c717-3eaf-e053-3a05fe0a5d97
|
91
|
|
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry), file e2f56ed8-6fe4-3eaf-e053-3a05fe0a5d97
|
82
|
|
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response, file e2f56ed8-8fc6-3eaf-e053-3a05fe0a5d97
|
78
|
|
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study, file e2f56ed9-6696-3eaf-e053-3a05fe0a5d97
|
76
|
|
Repurposing existing drugs for cardiovascular risk management: A focus on methotrexate, file e2f56ed8-c266-3eaf-e053-3a05fe0a5d97
|
72
|
|
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort, file e2f56eda-50ba-3eaf-e053-3a05fe0a5d97
|
61
|
|
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study, file e2f56eda-3b90-3eaf-e053-3a05fe0a5d97
|
55
|
|
Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes, file e2f56ed9-4dff-3eaf-e053-3a05fe0a5d97
|
54
|
|
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI), file e2f56ed9-8683-3eaf-e053-3a05fe0a5d97
|
50
|
|
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review, file e2f56eda-3b92-3eaf-e053-3a05fe0a5d97
|
49
|
|
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network, file e2f56ed9-a82d-3eaf-e053-3a05fe0a5d97
|
48
|
|
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography, file e2f56ed8-d3e3-3eaf-e053-3a05fe0a5d97
|
42
|
|
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome, file e2f56eda-af6b-3eaf-e053-3a05fe0a5d97
|
42
|
|
Gene expression profiling of monozygotic twins affected by psoriatic arthritis, file e2f56eda-2127-3eaf-e053-3a05fe0a5d97
|
41
|
|
Whole-body MRI in rheumatology: Major advances and future perspectives, file e2f56eda-2b5b-3eaf-e053-3a05fe0a5d97
|
41
|
|
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis, file e2f56eda-94c1-3eaf-e053-3a05fe0a5d97
|
38
|
|
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network, file e2f56eda-80a8-3eaf-e053-3a05fe0a5d97
|
37
|
|
Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study, file e2f56eda-9f6b-3eaf-e053-3a05fe0a5d97
|
36
|
|
Targeted Therapies in Axial Psoriatic Arthritis, file e2f56eda-5369-3eaf-e053-3a05fe0a5d97
|
35
|
|
Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: The UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol, file e2f56ed7-97b8-3eaf-e053-3a05fe0a5d97
|
32
|
|
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus, file 0aa075b3-3a2f-4c81-87d9-d532bcb711ab
|
19
|
|
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases, file 5d6e5114-00c9-4a8d-b8dc-217d647f51ee
|
18
|
|
Paziente con cirrosi epatica HCV correlata e sviluppo di artrite psoriasica indotta da INF-alfa = Opzioni terapeutiche e volontà del paziente-alpha induced psoriatic arthritis and HCV-related liver cirrhosis. Therapeutic options and patient's opinion, file e2f56ed8-e422-3eaf-e053-3a05fe0a5d97
|
18
|
|
Atherosclerosis and autoimmunity, file e2f56eda-d8df-3eaf-e053-3a05fe0a5d97
|
18
|
|
Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study, file e2f56eda-9fb4-3eaf-e053-3a05fe0a5d97
|
17
|
|
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus, file 741cfe3c-d797-4f5a-8711-391a6ac61cc9
|
14
|
|
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium, file c8db0b54-934f-4f17-b122-e05ebc50fbfb
|
13
|
|
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al. The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients, file e2f56ed9-58f9-3eaf-e053-3a05fe0a5d97
|
13
|
|
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations, file 2ffc3a28-79f2-439c-9881-fa1af18fabe5
|
11
|
|
Development and implementation of the AIDA International Registry for patients with Behçet's disease, file 3569b007-db84-4602-8b2b-666944d095a6
|
11
|
|
C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients, file 52a3ba8d-bf55-4117-b362-551640a877f2
|
11
|
|
Home tele-rehabilitation for rheumatic patients: impact and satisfaction of care analysis, file e2f56ed6-00c2-3eaf-e053-3a05fe0a5d97
|
11
|
|
The main challenges in systemic lupus erythematosus: Where do we stand?, file e2f56eda-a42f-3eaf-e053-3a05fe0a5d97
|
11
|
|
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome, file 59f9f534-c416-4c3b-a2ad-4562d6a8bf03
|
10
|
|
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study, file 88bd9002-2334-41c1-a4aa-65ef2a660181
|
10
|
|
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus, file e2f56ed7-3617-3eaf-e053-3a05fe0a5d97
|
10
|
|
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis, file 07695c35-7af6-42ec-ad27-363172aeae8c
|
8
|
|
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study, file 6a48167f-adeb-43d0-b16e-a970b8e37455
|
8
|
|
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study, file abca0362-e610-4716-9680-84e82f781cb6
|
8
|
|
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS), file 47b2635f-11f5-4df3-839a-787ca0a3da40
|
7
|
|
A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients, file e2f56ed3-9b7a-3eaf-e053-3a05fe0a5d97
|
6
|
|
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis, file e2f56ed6-6b46-3eaf-e053-3a05fe0a5d97
|
6
|
|
Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: Comparison with computed tomography, file e2f56eda-a1bc-3eaf-e053-3a05fe0a5d97
|
6
|
|
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study, file 973f01b9-8408-4c67-a41e-c82fe9733d47
|
5
|
|
Musculoskeletal manifestations in children with Behçet’s syndrome: data from the AIDA Network Behçet’s Syndrome Registry, file c0afc17d-cc17-4b44-8a55-976ebb424c6b
|
5
|
|
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicenter retrospective cross-sectional study on 959 Italian patients., file e2f56ed4-d9a4-3eaf-e053-3a05fe0a5d97
|
5
|
|
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review, file e2f56ed6-29f8-3eaf-e053-3a05fe0a5d97
|
5
|
|
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis, file e2f56ed7-bac8-3eaf-e053-3a05fe0a5d97
|
5
|
|
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies, file e2f56eda-ac08-3eaf-e053-3a05fe0a5d97
|
5
|
|
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis, file e2f56eda-d20c-3eaf-e053-3a05fe0a5d97
|
5
|
|
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry, file 01773203-18af-4140-973f-9e209bd75709
|
4
|
|
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society for Rheumatology, file 2f914ce5-cc60-4079-a864-b2638084f235
|
4
|
|
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study, file 6ce5c265-4764-4806-90fc-a9d65af61789
|
4
|
|
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology, file e2f56ed6-4eea-3eaf-e053-3a05fe0a5d97
|
4
|
|
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination, file e2f56ed7-13bb-3eaf-e053-3a05fe0a5d97
|
4
|
|
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia, file e2f56ed8-c57d-3eaf-e053-3a05fe0a5d97
|
4
|
|
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern, file e2f56eda-9abb-3eaf-e053-3a05fe0a5d97
|
4
|
|
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort, file e7e24232-adb1-4f52-8392-a1afe98f6532
|
4
|
|
Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study, file 3263b003-391b-46d7-b54c-cfd3ff3038b9
|
3
|
|
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project, file 53bbc3be-3af6-4f7f-9d82-6aedccf486ba
|
3
|
|
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study, file 8fea6e33-46f0-47a4-bd06-e0f8c30450b2
|
3
|
|
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort, file e2dacd3e-80ba-4147-8336-d18a0e643e53
|
3
|
|
Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region, file e2f56ed3-9682-3eaf-e053-3a05fe0a5d97
|
3
|
|
Familial chilblain and late contractural arachnodactyly: A novel association?, file e2f56ed3-9a14-3eaf-e053-3a05fe0a5d97
|
3
|
| Totale |
12.193 |